Follow a Drug, Company, Condition or Research Area
Every drug, sponsor and condition in the ClinicalTrials.gov registry - about 600,000 trials - has a page of its own, free to read. Press Follow on any of them and the changes come to you by email. For papers, follow any of dozens of healthcare research areas.
Follow a Drug
One page per drug, matched by MeSH term so brand and generic names meet: trials by phase and status, related conditions and sponsors, leading investigators, publications of results and the NIH grants behind the trials.
Follow it to get its new trials, results postings and status changes in your Daily Digest.
- Example: Pembrolizumab · Drugs A-Z
Follow a Biotech or Pharma Company
A sponsor page shows the company's pipeline: its trials by phase and status, its conditions and drugs, and the publications of its results. Trials where it is a collaborator rather than the lead sponsor are included.
Follow it to get every new trial it registers, every status change and every results posting.
- Example: Pfizer · Sponsors A-Z
Follow a Condition
One page per condition, including its narrower terms: the trials, the drugs being tested, the sponsors running them and the countries they run in. Or browse the day's new trials in any of 22 therapeutic areas.
Follow it to get its new trials in your Daily Digest, each marked with the reason.
- Example: Breast Neoplasms · Conditions A-Z · All areas
Follow a Research Area
Dozens of healthcare areas, such as oncology, cardiovascular medicine, infectious diseases and neurology. Each day's new papers from PubMed, medRxiv, bioRxiv and thousands of journals are placed in their areas and sorted by potential impact.
Follow an area to get its trending papers and its top new papers in your Daily Digest.
- Browse free: PubMed Daily · medRxiv Daily · Coverage preview
- Follow: Add areas, keywords and authors
One Digest for Trials, Papers, News and Discussions
More than 1,000 clinical trial records change every business day, and tens of thousands of new papers appear. The Daily Digest keeps only what matches what you follow, and puts the most important first. Read it in your inbox or online.
Clinical Trial Updates
New trials, posted results and status changes for the drugs, conditions and sponsors you follow. Routine edits to sites and contacts are left out.
Trending Papers
The papers in your areas that people are talking about, based on social and online metrics.
Keyword and Author Tracking
Papers matching the keywords and authors you follow - a drug name, a target, a principal investigator.
New Papers by Impact
The day's new papers from PubMed, medRxiv, bioRxiv and thousands of journals and conferences, sorted by potential impact.
Industry News
Trending industry news matching your interests, for a 1-5 minute scan.
Community Discussions
Top community discussions tailored to your research interests.
See a sample email → · Read your digest online → · About the Daily Digest →
Replace PubMed Alerts, Trial Alerts and Journal Emails
Most people who follow a field juggle PubMed alerts, registry feeds, preprint alerts and a stack of journal emails. The Healthcare Console brings them together, ranked by importance.
PubMed alerts
My NCBI saved searches email keyword matches in date order. The Daily Digest tracks the same keywords and authors across PubMed, ranked by potential impact, with a one-sentence highlight for each paper.
Clinical trial alerts
ClinicalTrials.gov offers an RSS feed per search. Here you follow a drug, company or condition once and get its new trials, results postings and status changes by email.
Journal table-of-contents emails
One email per journal. The Daily Digest follows your topics across thousands of journals and conferences at once.
medRxiv and bioRxiv alerts
Preprint alerts arrive per server, per category. Both servers are folded into the same digest as your published-paper tracking.
Conference abstracts
ASCO and AACR release thousands of papers at once. The conference digests index every paper by research area, with search and review by topic.
Industry news and discussions
Industry news and community discussions on your topics arrive in the same digest - things paper alerts never cover.
From Tracking to Analysis
When an update needs a closer look, the research tools open already set to healthcare sources.
Review Clinical Trials
An AI literature review over the clinical trials on a drug, target or condition.
Review trials →Review Biology and Healthcare Papers
A literature review limited to biology and healthcare papers.
Review papers →Review Government Grants
See what is being funded on a topic before the papers appear.
Review grants →Healthcare Research Report
A Deep Research report on any healthcare topic, under the healthcare model.
Start a report →Compare Trials Side by Side
Tick up to five trials in any list and open them in one table: intervention, design, enrollment, endpoint and results.
About the Literature Matrix →Try it: Review of Pembrolizumab trials · Report on Pembrolizumab
Free Daily Pages
Updated every business day, sorted so the most important come first - no account required.
ClinicalTrials Daily
Newly registered trials by therapeutic area, biggest first.
ClinicalTrials DailyOncology Conference Digests
Every accepted paper indexed by research area: browse by area, search and review by topic, follow papers by author, and connect each paper to the related literature.
ASCO 2026
Over 7,000 accepted papers across more than 20 specialized areas from the ASCO Annual Meeting.
ASCO 2026 papers & highlights →AACR 2026
Over 6,000 accepted papers across 200 specialized areas from the AACR Annual Meeting.
AACR 2026 papers & highlights →More Conferences and Journals
Browse, search and review the papers of thousands of journals and conferences by venue.
Conference digests → · Digest console →Built for People Who Follow the Field
Clinical Researchers and Fellows
Stay current in a specialty and build reviews for protocols, grants and manuscripts.
Medical Affairs and MSLs
Follow a therapeutic area's trials, papers and conference output in one place.
Clinical Development and Competitive Intelligence
Watch competitor drugs and sponsors: every new registration, status change and results posting.
Analysts and Investors
Follow a biotech's pipeline from its sponsor page and get its trial events by email.
Frequently Asked Questions
What is the Healthcare Console?
The Healthcare Console is the starting point for Paper Digest's healthcare services: a page for every drug, condition and sponsor in the ClinicalTrials.gov registry, daily lists of new clinical trials and new PubMed, medRxiv and bioRxiv papers, a Daily Digest that follows what you choose, read by email or online, and literature review and research report tools set to healthcare sources.
How do I track a drug?
Open the drug's page from the Drugs A-Z directory to see its trials by phase and status, the conditions it is tested in, its sponsors and the publications of results. Sign in and press Follow, and its new trials, results postings and status changes arrive in the Clinical Trial Daily Updates section of your Daily Digest email. Drugs are matched by MeSH term, so brand and generic names meet.
How do I track a biotech or pharma company's pipeline?
Open the company's sponsor page - for example Pfizer - to see its trials by phase and status, its conditions and drugs, and the publications of its results; then press Follow to get every new trial it registers, every status change and every results posting in your Daily Digest. Trials where the company is a collaborator rather than the lead sponsor are included.
How do I follow a condition or a disease area?
Each condition has a page that includes its narrower terms, and each of the 22 therapeutic areas has a daily list of newly registered trials. Press Follow on a condition page to get its new trials by email. For papers, add categories, keywords and authors on the update page of your console.
Is this an alternative to PubMed alerts?
Yes, for following topics. PubMed's own alerts (My NCBI saved searches) email keyword matches in date order. The Daily Digest tracks the same keywords and authors, ranks the matches by potential impact, adds a one-sentence highlight for each paper, and covers medRxiv, bioRxiv, clinical trials and industry news in the same digest. PubMed Daily is free to browse without an account.
How do doctors and clinical researchers keep up with new research?
Most combine journal table-of-contents emails, PubMed alerts, guidelines, conferences and summary services. The Healthcare Console replaces the alert part: one digest for the new papers, clinical trials, industry news and discussions on the topics, drugs and companies you follow.
What is free, and what needs a membership?
The daily clinical trial list, the therapeutic area pages, the drug, condition and sponsor pages, the trial pages, and PubMed Daily, medRxiv Daily and bioRxiv Daily are free, with no account. Following by email, side-by-side comparison, literature reviews and research reports are for Paper Digest members. Membership is $10.99 per month and gives full access to every tool.
Which sources are covered?
Clinical trials come from the ClinicalTrials.gov registry: about 600,000 trials with their posted results. Papers come from PubMed, medRxiv, bioRxiv, arXiv and thousands of journals and conferences, including the ASCO and AACR annual meetings. The Daily Digest adds industry news and community discussions.
How often is it updated?
Every business day. The trial index picks up the 1,000-plus registry records that were registered or changed, and the daily paper pages list the newly published papers.
Is the Healthcare Console an UpToDate alternative?
No - it complements it. UpToDate is a point-of-care clinical reference with expert-written topic reviews. The Healthcare Console tracks what is new: the papers, clinical trials and conference abstracts appearing each day on the topics you follow.
Is this medical advice?
No. The Healthcare Console is a research and monitoring tool for professionals. It is not medical advice or clinical decision support, and AI-generated reviews and reports should be checked against the sources they cite.
More reading: How to keep up with the latest research in your field · Full FAQ
Ready to Start?
Follow your first drug, company or condition today, and the updates start the next business day - by email or online.